United States: Yearly Stock Market Performance Insight - 2004

Yearly Gainers
1,350
Yearly Losers
499
Average Return
44.12%
Total Stocks
1,931
View Detailed Market Cap Breakdown
Market Cap Yearly Gainers Yearly Losers Average Return Total Stocks
Mega Cap 24 10 13.13% 36
Large Cap 385 78 27.83% 474
Mid Cap 321 107 61.43% 449
Small Cap 119 38 53.37% 168

Yearly Streak Leaders for 2004

Stock Streak Streak Return
6 years โ†‘ 704.57%

UnitedHealth solidifies its market leadership with a 6-year growth streak (5.47 โ†’ 44.01), delivering 704.6% cumulative returns. With 109.6B annual revenue generating only 6.5B profit (5.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†‘ 107.37%

Bank of America builds shareholder value with a 4-year growth streak (22.66 โ†’ 46.99), delivering 107.4% cumulative returns. With 27.4B annual revenue generating only 7.4B profit (27.0% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

6 years โ†“ -51.28%

AT&T endures extended market pressure with a 6-year decline (39.94 โ†’ 19.46), down 51.3% cumulatively. Yet fundamentals remain solid: 30.6B annual revenue generating 4.7B profit (15.3% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

1 years โ†“ -57.18%

Netflix posts annual decline with a 1-year decline (4.11 โ†’ 1.76), down 57.2% cumulatively. Yet fundamentals remain solid: 10.5B annual revenue generating 2.9B profit (27.4% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

14 years โ†‘ 3,789.29%

Brown & Brown continues its impressive multi-year expansion with a 14-year growth streak (0.28 โ†’ 10.89), delivering 3,789.3% cumulative returns. Annual financials validate this performance: 1.4B revenue generating 334.0M net profit (24.1% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

11 years โ†‘ 2,872.34%

Expeditors continues its impressive multi-year expansion with a 11-year growth streak (0.94 โ†’ 27.94), delivering 2,872.3% cumulative returns. With 2.7B annual revenue generating only 204.1M profit (7.7% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†“ -74.73%

Regeneron struggles through multi-year headwinds with a 4-year decline (36.44 โ†’ 9.21), down 74.7% cumulatively. Weak margins on 3.0B annual revenue with only 808.7M profit (26.7% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†“ -63.69%

Merck & Co endures extended market pressure with a 4-year decline (84.42 โ†’ 30.65), down 63.7% cumulatively. Yet fundamentals remain solid: 15.5B annual revenue generating 5.1B profit (32.7% margin) as of Qtr ending Mar 2025 suggests this could be a value opportunity. Contrarian investors take note.

10 years โ†‘ 1,212.03%

Simpson solidifies its market leadership with a 10-year growth streak (2.66 โ†’ 34.90), delivering 1,212.0% cumulative returns. Annual financials validate this performance: 538.9M revenue generating 77.9M net profit (14.5% margin) demonstrates exceptional profit margins as of Qtr ending Mar 2025.

8 years โ†‘ 1,923.08%

Oshkosh demonstrates exceptional long-term growth with a 8-year growth streak (1.69 โ†’ 34.19), delivering 1,923.1% cumulative returns. With 2.3B annual revenue generating only 112.2M profit (4.9% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

4 years โ†“ -81.71%

ASGN endures extended market pressure with a 4-year decline (28.38 โ†’ 5.19), down 81.7% cumulatively. Weak margins on 968.3M annual revenue with only 20.9M profit (2.2% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

4 years โ†“ -82.57%

Bruker endures extended market pressure with a 4-year decline (23.12 โ†’ 4.03), down 82.6% cumulatively. Weak margins on 801.4M annual revenue with only 16.8M profit (2.1% margin) in Qtr ending Mar 2025 validate market skepticism. Structural improvements needed before recovery.

5 years โ†‘ 814.86%

Pediatrix Medical solidifies its market leadership with a 5-year growth streak (1.75 โ†’ 16.01), delivering 814.9% cumulative returns. While annual revenue reaches 458.4M, net income of 20.7M (4.5% margin) in Qtr ending Mar 2025 shows the company prioritizes growth over margins - common for expanding Healthcare players.

5 years โ†‘ 572.38%

National Healthcare solidifies its market leadership with a 5-year growth streak (5.25 โ†’ 35.30), delivering 572.4% cumulative returns. With 373.7M annual revenue generating only 32.3M profit (8.6% margin) in Qtr ending Mar 2025, the market prices in significant margin expansion ahead.

5 years โ†“ -88.48%

Biolife Solutions struggles through multi-year headwinds with a 5-year decline (10.94 โ†’ 1.26), down 88.5% cumulatively. Financial struggles compound yearly losses: despite 23.9M annual revenue, - 448,000 losses persist (-1.9% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

3 years โ†“ -78.71%

Sarepta Therapeutics encounters consecutive annual declines with a 3-year decline (66.24 โ†’ 14.10), down 78.7% cumulatively. Financial struggles compound yearly losses: despite 744.9M annual revenue, - 447.5M losses persist (-60.1% margin) as of Qtr ending Mar 2025. Turnaround remains elusive.

United States Market Yearly Gainers & Losers: 2004

Top United States Stock Gainers (2004)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$0.38 $1.15 202.63% 483.3M 121.8B
$29.52 $44.01 51.29% 6.5M 1.6B
$15.10 $22.02 47.79% 10.9M 2.7B
$37.19 $48.41 30.20% 3.5M 888.9M
$24.95 $32.06 29.12% 4.5M 1.1B
$5.84 $31.85 444.44% 532.5K 134.2M
$6.91 $31.65 361.37% 21.5M 5.4B
$26.91 $115.95 335.74% 86.1K 21.7M
$0.09 $0.38 322.22% 19.5M 4.9B
$14.50 $45.74 216.10% 2.5M 617.6M
$1.09 $1.68 16,700.00% 7.0K 1.8M
$282.00 $998.00 253.90% 1.1K 281.1K
$8.87 $29.64 234.92% 200.6K 50.6M
$19.50 $43.20 232.31% 3.9K 990.8K
$4.66 $12.75 174.19% 52.2K 13.2M
$0.04 $1.73 4,225.00% 33.2K 8.4M
$5.60 $20.27 263.91% 110.0K 27.7M
$0.81 $2.94 258.54% 529.3K 133.4M
$5.50 $15.70 187.02% 5.0M 1.3B
$63.75 $167.15 167.01% 74.4K 18.8M

Biggest United States Stock Losers (2004)

Stock Year Open Year Close Yearly Change Avg Daily Volume Year Volume
$4.11 $1.76 -54.99% 24.0M 6.1B
$24.36 $19.32 -20.26% 54.7M 13.8B
$70.85 $56.75 -19.31% 3.6M 911.4M
$25.40 $20.82 -17.97% 12.2M 3.1B
$26.41 $22.00 -16.76% 4.6M 1.2B
$10.36 $3.83 -62.15% 231.7K 58.4M
$47.25 $23.38 -49.09% 1.8M 457.8M
$33.73 $19.55 -42.26% 1.8M 463.9M
$14.81 $9.21 -37.39% 406.1K 102.3M
$16.74 $10.75 -34.89% 660.4K 166.4M
$126.60 $33.90 -71.36% 7.5K 1.9M
$4.00 $1.29 -67.75% 56.6K 14.3M
$7.05 $1.80 -67.57% 1.1K 276.5K
$26.70 $9.13 -64.95% 482.5K 121.6M
$17.90 $6.68 -63.18% 2.2M 550.3M
$0.85 $0.34 -62.22% 63.7K 16.1M
$12.35 $5.08 -52.83% 432.0K 108.9M
$122.80 $65.20 -45.67% 9.8K 2.5M
$24.66 $14.10 -42.26% 53.6K 13.5M
$14.29 $8.62 -40.06% 1.3M 340.0M

Most Active United States Stocks During 2004

Stock Year Open Year Close Yearly Change Avg Daily Volume Yearly Volume
$32.36 $23.39 -27.02% 65.4M 16.5B
$13.54 $24.48 80.00% 41.8M 10.5B
$22.61 $17.10 -23.80% 32.4M 8.2B
$3.26 $2.89 -10.53% 27.6M 7.0B
$33.61 $25.51 -23.90% 24.4M 6.1B
$5.86 $4.79 -18.54% 36.4M 9.2B
$11.19 $27.47 146.59% 31.3M 7.9B
$9.36 $7.65 -18.53% 22.8M 5.7B
$16.70 $14.43 -12.86% 7.2M 1.8B
$33.50 $76.20 141.14% 6.7M 1.7B
$5.50 $15.70 187.02% 5.0M 1.3B
$4.63 $5.14 11.74% 4.6M 1.2B
$14.20 $13.98 0.79% 4.5M 1.1B
$17.76 $15.48 -12.44% 3.3M 821.0M
$11.93 $21.24 78.49% 2.3M 589.3M

United States Sector Performance During 2004

Basic Materials

194.28%
105 stocks
Top Performers by Market Cap:
Mega Cap: LIN +15.58%
Large Cap: MT +335.74%
Small Cap: SKE +114.29%

Energy

55.07%
83 stocks
Top Performers by Market Cap:
Mega Cap: XOM +25.02%
Large Cap: LNG +444.44%
Small Cap: RES +128.28%

Industrials

45.25%
298 stocks
Top Performers by Market Cap:
Mega Cap: GE +17.82%
Large Cap: AXON +361.37%
Small Cap: NSSC +258.54%

Consumer Cyclical

36.07%
231 stocks
Top Performers by Market Cap:

Technology

33.74%
262 stocks
Top Performers by Market Cap:

Healthcare

28.33%
235 stocks
Top Performers by Market Cap:
Mega Cap: UNH +51.29%
Large Cap: ISRG +134.21%
Small Cap: UFPT +94.36%

Financial Services

27.76%
375 stocks
Top Performers by Market Cap:
Mega Cap: AXP +16.86%
Large Cap: CME +216.10%
Small Cap: WT +4,225.00%

Communication Services

26.15%
61 stocks
Top Performers by Market Cap:
Mega Cap: DIS +19.11%
Large Cap: RCI +58.42%
Small Cap: LGF.A +137.05%

Consumer Defensive

25.99%
96 stocks
Top Performers by Market Cap:
Mega Cap: COST +30.20%
Large Cap: MNST +322.22%
Mid Cap: DAR +57.97%
Small Cap: UNFI +73.26%

Real Estate

24.50%
106 stocks
Top Performers by Market Cap:
Large Cap: SBAC +146.81%
Mid Cap: JOE +72.16%
Small Cap: ALX +72.47%

Utilities

17.00%
60 stocks
Top Performers by Market Cap:
Large Cap: NRG +64.57%
Mid Cap: AES +44.81%
Small Cap: HE +23.10%

Data is updated regularly. Yearly performance is calculated based on closing prices.